Seglitide acetate

CAS No. 99248-33-6

Seglitide acetate( —— )

Catalog No. M34418 CAS No. 99248-33-6

Seglitide acetate (MK-678) is a selective agonist of sst2 somatostatin receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 211 In Stock
10MG 330 In Stock
25MG 548 In Stock
50MG 765 In Stock
100MG 1014 In Stock
200MG 1386 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Seglitide acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Seglitide acetate (MK-678) is a selective agonist of sst2 somatostatin receptor.
  • Description
    Seglitide acetate (MK-678) is a selective agonist of sst2 somatostatin receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Somatostatin Receptor
  • Recptor
    Somatostatin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    99248-33-6
  • Formula Weight
    869.02
  • Molecular Formula
    C46H60N8O9
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C)(O)=O.C(C=1C=2C(NC1)=CC=CC2)[C@H]3NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](C)N(C)C(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)C)NC(=O)[C@H](CCCCN)NC3=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Paltusotine

    Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels in acromegaly patients

  • CYN 154806 TFA(18365...

    CYN 154806 (TFA) is a cyclic octapeptide and an effective selective somatostatin sst2 receptor antagonist. For the recombinant sst2, sst1, sst3, sst4 and sst5 receptors, the pIC50 values are 8.58, 5.41, 6.07, 5.76 and 6.48, respectively.

  • Octreotide acetate

    An octapeptide that mimics natural somatostatin pharmacologically, that is 200 times more potent than somatostatin.